NZ229453A - A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents - Google Patents

A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents

Info

Publication number
NZ229453A
NZ229453A NZ229453A NZ22945389A NZ229453A NZ 229453 A NZ229453 A NZ 229453A NZ 229453 A NZ229453 A NZ 229453A NZ 22945389 A NZ22945389 A NZ 22945389A NZ 229453 A NZ229453 A NZ 229453A
Authority
NZ
New Zealand
Prior art keywords
azt
nucleosides
pharmaceutical composition
composition containing
antiviral agents
Prior art date
Application number
NZ229453A
Other languages
English (en)
Inventor
Robert Vince
William M Shannon
Original Assignee
Univ Minnesota & Southern Rese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota & Southern Rese filed Critical Univ Minnesota & Southern Rese
Publication of NZ229453A publication Critical patent/NZ229453A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ229453A 1988-06-10 1989-06-08 A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents NZ229453A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20516388A 1988-06-10 1988-06-10

Publications (1)

Publication Number Publication Date
NZ229453A true NZ229453A (en) 1991-08-27

Family

ID=22761073

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ229453A NZ229453A (en) 1988-06-10 1989-06-08 A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents

Country Status (9)

Country Link
EP (1) EP0346132B1 (OSRAM)
JP (1) JPH0291022A (OSRAM)
AT (1) ATE73335T1 (OSRAM)
AU (1) AU627188B2 (OSRAM)
DE (1) DE68900961D1 (OSRAM)
DK (1) DK284189A (OSRAM)
GR (1) GR3004628T3 (OSRAM)
NZ (1) NZ229453A (OSRAM)
ZA (1) ZA894392B (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB2243609B (en) * 1988-01-20 1992-03-11 Univ Minnesota Dideoxydidehydrocarbocyclic pyrimidines
IE62275B1 (en) * 1988-01-20 1995-01-25 Univ Minnesota Dideoxydidehydrocarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
EP0879056B1 (en) * 1996-01-23 2002-05-02 ICN Pharmaceuticals, Inc. Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes
EP0998293A4 (en) * 1997-01-17 2002-07-17 Icn Pharmaceuticals TREATMENTS FOR CYTOKIN-RELATED DISEASES
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
MY119656A (en) * 1997-12-22 2005-06-30 Schering Corp Orally administrable solid ribavirin dosage forms and process for making them
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA007867B1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
ATE314851T1 (de) * 2002-06-27 2006-02-15 Medivir Ab Synergistische wechselwirkung von abacavir und alovudin
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
MXPA05005192A (es) 2002-11-15 2005-09-08 Idenix Cayman Ltd Nucleosidos ramificados en la posicion 2' y mutacion de flaviviridae.
WO2006122003A2 (en) * 2005-05-05 2006-11-16 Ardea Biosciences, Inc. Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
US7968521B2 (en) 2005-06-24 2011-06-28 Yamasa Corporation Stable cystal of protected pseudouridine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4362729A (en) * 1980-06-23 1982-12-07 The Regents Of The University Of Minnesota Alkoxyalkanoate esters of cyclaradine
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination
DE58902899D1 (de) * 1988-12-14 1993-01-14 Ciba Geigy Ag 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.

Also Published As

Publication number Publication date
EP0346132A1 (en) 1989-12-13
DK284189D0 (da) 1989-06-09
DK284189A (da) 1989-12-11
GR3004628T3 (OSRAM) 1993-04-28
AU627188B2 (en) 1992-08-20
EP0346132B1 (en) 1992-03-11
ZA894392B (en) 1990-08-29
ATE73335T1 (de) 1992-03-15
JPH0291022A (ja) 1990-03-30
DE68900961D1 (de) 1992-04-16
AU3627289A (en) 1989-12-14

Similar Documents

Publication Publication Date Title
NZ229453A (en) A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
AU1787492A (en) Antiviral combinations containing nucleoside analogs
DK0545966T3 (da) Phospholipidderivater af nucleosider, deres fremstilling samt deres anvendelse som anti-virale lægemidler
CA2100269A1 (en) Use of 1, 3-Oxathiolane Nucleoside Analogues in the Treatment of Hepatitis B
IL99755A0 (en) Hydroxymethyl(methylenecyclopentyl)purines and pyrimidines and pharmaceutical compositions containing the same
IL93050A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ216172A (en) Nucleosides and pharmaceutical compositions
MD1434C2 (ro) Analogi nucleozidici ai 1,3-oxatiolanului, compoziţie farmaceutică conţinând analogi nucleozidici ai 1,3-oxatiolanului şi metodă de tratament al infecţiilor virale
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
RU95109100A (ru) Производные ксантина, смесь их изомеров или отдельные изомеры и их фармакологически переносимые соли и фармацевтическая композиция с антагонистической в отношении аденозина активностью на их основе
HUT72460A (en) Synergetic antiviral nucleoside combination, pharmaceutical preparation containing thereof, method of preparation, and use
CA2479846A1 (en) Phosphonomethoxymethylpurine/pyrimidine derivatives
AU7776891A (en) 5-benzyl barbiturate derivatives
ZA892407B (en) 6-substituted acyclopyrimidine nucleoside derivative and antiviral agent containing the same as active ingredient thereof
ES2108717T3 (es) Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
DK0570294T3 (da) 2-formylpyridinthiosemicarbazonderivater, deres fremstilling og deres anvendelse som antitumormiddel
CA2127472A1 (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
DE68900760D1 (de) Virushemmende nukleosidmischung.
GR3024028T3 (en) Cytotoxic and antiviral compound.
ES2134259T3 (es) Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos.
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
US5378844B1 (en) 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives preparation process and antidepressant nootropic and psychostimulant composition thereof
ES2092470T3 (es) Derivados de pirrolidina.
IL103855A0 (en) 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
ZA896230B (en) Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodefeciency syndrome